Two Ohio facilities to pay $108M in cardiac kickback case

May 20, 2010

Two Ohio hospitals today agreed to pay the U.S. government $108 million to settle claims that the institutions violated federal law by unlawfully paying doctors for referrals of cardiac patients.

Click here to read the rest of the article.

Latest in Cardiac Imaging
Insurance Claim Reimbursement Vinnstock
Cleerly highlights coverage decision effective October 1
September 30, 2025
Heart Glowing Red
HeartFlow secures 510(k) for next-gen algorithm
September 23, 2025
Digital Innovations Shaping the Future of Radiology
Sponsored
Digital Innovations Shaping the Future of Radiology
September 24, 2025
Representative axial images of mild, moderate, and severe emphysema at baseline low-dose CT (LDCT). Participants were categorized as having no emphysema or mild, moderate, or severe emphysema. When present, emphysema was mild if no distinct regions of reduced attenuation were visible on the CT scan, but vascular splaying indicates parenchymal expansion, or if only occasional discrete low-attenuation regions were observed. Moderate emphysema was defined by the presence of identifiable low-attenuation regions affecting less than half of the lung parenchyma, whereas severe emphysema was defined by the presence of identifiable low-attenuation regions that involved more than half of the lung parenchyma. A scoring system from 0 to 3 was applied, corresponding to none, mild, moderate, and severe emphysema, respectively. Yellow circle indicates the extent of emphysema. (A) A 67-year-old man with mild emphysema at baseline LDCT in 2002. Baseline LDCT scan shows vascular splaying, suggesting parenchymal expansion due to emphysema and occasional discrete low-attenuation regions. The participant ultimately died of cardiovascular disease 15.4 years (184.2 months) later. (B) A 69-year-old man with moderate emphysema at baseline LDCT in 2007. The participant died of cardiovascular disease 1.8 years (21.9 months) later. Identifiable low-attenuation regions affected less than half of the lung parenchyma. (C) An 85-year-old woman with severe emphysema at baseline LDCT in 2006. After 5.5 years (65.5 months) of follow-up, the participant died due to chronic obstructive pulmonary disease–related causes. Identifiable low-attenuation regions involved more than half of the lung parenchyma.
Low-dose CT ties emphysema to mortality in previous smokers
September 9, 2025
Related Stories
2010 05 19 09 18 41 678 Halliburton thumb 05 10
CT
Reduced-voltage cardiac CT works fine -- if you know the rules
2010 04 30 10 50 22 865 2010 05 05 Dr Thumb
CT
Researchers eye dual-energy DR as calcium-scoring option
2010 04 02 13 04 23 658 Kufner thumb 04 10
CT
Less DNA damage seen after high-pitch coronary CTA
Digital Innovations Shaping the Future of Radiology
Sponsor Content
Digital Innovations Shaping the Future of Radiology
More in Cardiac Imaging
Cleerly highlights coverage decision effective October 1
By AuntMinnie.com staff writers
Cleerly's AI-QCT software for cardiovascular imaging will be eligible for reimbursement from UnitedHealthcare and Cigna on October 1.
September 30, 2025
Insurance Claim Reimbursement Vinnstock
HeartFlow secures 510(k) for next-gen algorithm
By AuntMinnie.com staff writers
Corresponding with the FDA clearance, the company also highlighted the unveiling of its DECIDE Registry.
September 23, 2025
Heart Glowing Red
Tempus AI secures 510(k) for Pixel
By AuntMinnie.com staff writers
The update reflects new software functionality designed for a comprehensive view of heart tissue.
September 12, 2025
Cardiac Heart Eeg Social (1)
Low-dose CT ties emphysema to mortality in previous smokers
By Amerigo Allegretto
Study findings highlight the clinical relevance of CT-diagnosed emphysema.
September 9, 2025
Representative axial images of mild, moderate, and severe emphysema at baseline low-dose CT (LDCT). Participants were categorized as having no emphysema or mild, moderate, or severe emphysema. When present, emphysema was mild if no distinct regions of reduced attenuation were visible on the CT scan, but vascular splaying indicates parenchymal expansion, or if only occasional discrete low-attenuation regions were observed. Moderate emphysema was defined by the presence of identifiable low-attenuation regions affecting less than half of the lung parenchyma, whereas severe emphysema was defined by the presence of identifiable low-attenuation regions that involved more than half of the lung parenchyma. A scoring system from 0 to 3 was applied, corresponding to none, mild, moderate, and severe emphysema, respectively. Yellow circle indicates the extent of emphysema. (A) A 67-year-old man with mild emphysema at baseline LDCT in 2002. Baseline LDCT scan shows vascular splaying, suggesting parenchymal expansion due to emphysema and occasional discrete low-attenuation regions. The participant ultimately died of cardiovascular disease 15.4 years (184.2 months) later. (B) A 69-year-old man with moderate emphysema at baseline LDCT in 2007. The participant died of cardiovascular disease 1.8 years (21.9 months) later. Identifiable low-attenuation regions affected less than half of the lung parenchyma. (C) An 85-year-old woman with severe emphysema at baseline LDCT in 2006. After 5.5 years (65.5 months) of follow-up, the participant died due to chronic obstructive pulmonary disease–related causes. Identifiable low-attenuation regions involved more than half of the lung parenchyma.
eMyosound to start cardiac ultrasound trial in 3 Boston hospitals
By AuntMinnie.com staff writers
The trial will validate eMyosound technology for the quantitative assessment of myocardial stiffness in patients with heart failure.
September 8, 2025
Heart Ultrasound Adobe Peakstock
GE HealthCare unveils AI-loaded cardiovascular ultrasound system
By AuntMinnie.com staff writers
Adaptive cardiovascular ultrasound system redesigned for 2D, 4D, and color flow imaging.
August 29, 2025
Ge Healthcare Logo 8uqm Sjnztb
Echo images show consequences of steroid use among athletes
By Amerigo Allegretto
Echocardiography shows how anabolic steroid use among athletes impacts heart health.
August 29, 2025
Athlete Runner Chest Pain
DESKi launches cardiac AI software
By AuntMinnie.com staff writers
The software has been integrated into Butterfly Network’s handheld ultrasound devices.
August 27, 2025
Echocardiography
Philips cardiology snapshot highlights challenges for patient care, trust in AI
By AuntMinnie.com staff writers
Royal Philips shared findings from its Future Health Index cardiology snapshot that show challenges in cardiac care and AI.
August 26, 2025
Philips Rsna 2019 400
Esaote lands FDA clearance for two new MyLab ultrasound systems
By AuntMinnie.com staff writers
Esaote has received U.S. Food and Drug Administration (FDA) clearance to market its MyLab A50 and MyLab A70 ultrasound systems.
August 22, 2025
MyLab A70 ultrasound system.
United Healthcare to cover Elucid's PlaqueIQ
By AuntMinnie.com staff writers
A new guideline released by the insurer now includes coronary computed tomography angiography plaque quantification and specifically refers to PlaqueIQ.
August 11, 2025
Plaque Artery
SCCT: Saurabh Jha on what trainees can expect starting out in cardiac CT
By Liz Carey
Within the broad category of cardiac imaging, coronary CT is poised for expansion, according to Saurabh Jha, MD.
July 21, 2025
Jha Saurabh Thumbnail
Page 1 of 323
Next Page